Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.480
-0.020 (-0.80%)
At close: Oct 29, 2026, 4:00 PM EDT
2.400
-0.080 (-3.23%)
Pre-market: Oct 30, 2026, 4:03 AM EDT
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $56.41 million as of October 29, 2026. It is the 29,151st most valuable company in the world and the 4,521st biggest in the United States. Its market cap has increased by 72.61% in one year.
Market Cap
56.41M
Enterprise Value
-16.21M
1-Year Change
72.61%
Global Rank
Country Rank
#4,521 United States
Category
ChartMarket Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $56.41M, a decrease of -84.15%. That is a compound annual growth rate of -50.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 56.41M | 110.01% |
| Dec 31, 2025 | 26.86M | -58.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rein Therapeutics | 59.75M |
| XBiotech | 59.60M |
| OS Therapies | 58.22M |
| Heron Therapeutics | 58.11M |
| MindWalk Holdings | 56.77M |
| Clene | 56.50M |
| Oncolytics Biotech | 55.75M |
| MiNK Therapeutics | 55.27M |